Clinical Trial Update: Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation

View source ↗

Summary

The National Cancer Institute-sponsored clinical trial assessing relapse in malignant blood cancers after allogeneic hematopoietic stem cell transplantation was…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia | Status: TERMINATED | Results posted: 2018-06-06